Over the past year, many Cencora, Inc. ( NYSE:COR ) insiders sold a significant stake in the company which may have... CONSHOHOCKEN, Pa., February 07, 2025--Cencora, Inc. (NYSE: COR) today ...

But on the bright side, you can make far more than 100% on a really good stock. Long term Cencora, Inc. (NYSE:COR) shareholders would be well aware of this, since the stock is up 156% in five years.

Last week, representatives from Cencora, formerly known as Amerisource Bergen, visited Keystone Health to gain insights into community health centers and their 340B programs. Joy Rowan and Joel ...

Outlook Therapeutics remains confident that ONS-5010 / LYTENAVA™ is an important therapy for the treatment of wet AMD in place of off-label repackaged bevacizumab that has not received ... Outlook ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Alex Guillen, global pharma and life sciences director at Tive, shares how the development of technology will ...

After hours: 7:44:11 p.m. EST ...

The upgraded unit will soon be making its way to neighborhoods across the region, driving improvements in community health outcomes. Last week, representatives from Cencora, formerly known as ...